Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials

Autor: Yothers, G, Sargent, Dj, Wolmark, N, Goldberg, Rm, O'Connell, Mj, Benedetti, Jk, Saltz, Lb, Dignam, Jj, Blackstock, Aw, Green, E, Grothey, A, Alberts, Sr, Bot, B, Campbell, M, Shi, Q, de Gramont, A, Gray, R, Kerr, D, Haller, Dg, Buyse, M, Labianca, R, Seitz, Jf, O'Callaghan, Cj, Francini, G, Catalano, Pj, Blanke, Cd, Andre, T, Sanoff, H, Benson, A, ACCENT Collaborative Group

Publikováno v: JNCI Journal of the National Cancer Institute. 103:1498-1506

Background Among patients with resected colon cancer, black patients have worse survival than whites. We investigated whether disparities in survival and related endpoints would persist when patients were treated with identical therapies in controlle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73888857f6933ff8b977b0d65e50b67c
https://doi.org/10.1093/jnci/djr310

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

Autor: Sargent, D, Shi, Q, Yothers, G, Van Cutsem, E, Cassidy, J, Saltz, L, Wolmark, N, Bot, B, Grothey, A, Buyse, M, de Gramont, A, Green, E, Alberts, Sr, Campbell, M, O'Connell, Mj, Gray, R, Kerr, D, Haller, Dg, Benedetti, J, Labianca, R, Seitz, Jf, O'Callaghan, Cj, Francini, G., Catalano, Pj, Blanke, Cd, Andre, T, Goldberg, Rm, Benson, A, Twelves, C, Sirzen, F, Cisar, L, Adjuvant Colon Cancer End-points (ACCENT) Group

Background The ACCENT group previously established disease-free survival (DFS) with 2 or 3 years median follow-up to predict 5 year overall survival (5 year OS) in stage II and III colon cancer. ACCENT further proposed (1) a stronger association betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e429c15f53de8e8cc525e593e7e05ea7
http://hdl.handle.net/11365/37202

Elevated Serum Gastrin Levels in Patients with Colorectal Neoplasia

Autor: Marc Giovannini, Gouvernet J, Gauthier A, Seitz Jf

Publikováno v: Journal of Clinical Gastroenterology. 13:541-545

Gastrin stimulates the growth of some human colon adenocarcinomas grown in vitro or as xenografts in nude mice. To evaluate the possibility of elevated plasma gastrin levels in patients with adenomatous polyps or colorectal cancer, we carried out a r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8497efcda11bc1833306dad747d2c7ae
https://doi.org/10.1097/00004836-199110000-00013

Concurrent concentrated chemoradiation therapy in squamous cell carcinoma of the esophagus: long term results of a national multicenter phase II study in 122 inoperable patients (FFCD 8803)

Autor: Seitz, JF, Milan, C, Giovannini, M, Dumas, F, Cauvin, JM, Conroy, T, Francois, E, Renard, P, Votte-Lambert, A, Paillot, B, Bedenne, L, Canc, Federation Natl Ctr Lutte

Publikováno v: Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2000, 24 (2), pp.201-210
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2000, 24 (2), pp.201-210

International audience; Objectives-Concomitant radiochemotherapy improves survival from inoperable esophageal cancer compared to radiotherapy alone. Several regimens of radiotherapy (standard or concentrated split course radiotherapy) are used, howev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::438e799b6d92ba32c07395ec32a408c7
https://hal.science/hal-01441707

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.